← Back to Search

Radiation Therapy

IORT for Breast Cancer

N/A
Recruiting
Led By Janie Grumley, MD
Research Sponsored by John Wayne Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights

Summary

This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disease Recurrence
Secondary study objectives
Disease specific survival
Overall Survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: IORTExperimental Treatment1 Intervention
All participants who plan to undergo partial mastectomy for treatment of early stage breast cancer will be considered for eligibility for IORT. Patient with single breast cancer less than 3cm in disease span, clinical negative axillary node will be offered the option of having IORT. If IORT is delivered following surgical resection of the tumor they will be followed in this registry for short and long term outcomes.

Find a Location

Who is running the clinical trial?

John Wayne Cancer InstituteLead Sponsor
21 Previous Clinical Trials
4,549 Total Patients Enrolled
3 Trials studying Breast Cancer
46 Patients Enrolled for Breast Cancer
Saint John's Cancer InstituteLead Sponsor
25 Previous Clinical Trials
5,795 Total Patients Enrolled
3 Trials studying Breast Cancer
46 Patients Enrolled for Breast Cancer
Janie Grumley, MD5.07 ReviewsPrincipal Investigator - John Wayne Cancer Institute, Providence Saint John's Health Center
John Wayne Cancer Institute
1 Previous Clinical Trials
500 Total Patients Enrolled
1 Trials studying Breast Cancer
500 Patients Enrolled for Breast Cancer
5Patient Review
I had a great experience working with Dr. Grumley. She is very knowledgeable about breast cancer and was able to answer all of my questions. She also made sure to involve my family in the decision-making process, which was really important to me. I felt like I could always reach out to her with questions, and she always responded quickly. I would definitely recommend her to anyone facing breast cancer.
~400 spots leftby Oct 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top